{
  "docId": "019de514-833c-7520-a4a9-200b68fbb681",
  "docSlug": "d869e39fe11534a9d64784c9e4f475f2",
  "documentTitle": "Bausch+Lomb | Results Presentation Deck | 47 slides",
  "authorId": "bausch-lomb",
  "authorName": "Bausch + Lomb",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 8,
  "pageCount": 47,
  "prevPage": 7,
  "nextPage": 9,
  "slideType": "kpi_overview",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 15,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de514-833c-7520-a4a9-200b68fbb681/8",
  "deckHref": "/decks/019de514-833c-7520-a4a9-200b68fbb681",
  "deckJsonHref": "/decks/019de514-833c-7520-a4a9-200b68fbb681.json",
  "deckAnchorHref": "/decks/019de514-833c-7520-a4a9-200b68fbb681#slide-8",
  "components": [
    {
      "bbox": {
        "h": 0.21,
        "w": 0.21,
        "x": 0.07,
        "y": 0.46
      },
      "kind": "chart",
      "text": "Ophthalmic Pharmaceuticals 18%\nSurgical 18%\nVision Care 64%",
      "attrs": null,
      "subkind": "pie",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7f66da80-9ce9-49bb-bf2b-f43e9b2f17ec",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.12,
        "x": 0.04,
        "y": 0.94
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d1824891-6a17-4407-bdf1-d1e55f887414",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.61,
        "w": 0.16,
        "x": 0.814,
        "y": 0.201
      },
      "kind": "list",
      "text": "Expanding Into New Product Categories\nEntered into an exclusive European distribution agreement for MIMS® minimally invasive surgical procedure for treatment of glaucoma\nLuxSmart ™™ Premium IOL launched in 19 countries",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2c0bc9fa-8979-4b0f-a8c5-b33a003a0033",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.701,
        "w": 0.202,
        "x": 0.58,
        "y": 0.201
      },
      "kind": "list",
      "text": "Investing in Categories Growing Faster Than Market\n~49% U.S. weekly market share for Lumify® in Redness Reliever Category³; strong early launch in Canada\n~24% CAGR (2016-2021)4 U.S. prescription dry eye market; expect double digit growth 2021-20275\nNOV03 PDUFA Date June 2023",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "88fb5345-f330-426b-ba69-7826e310bc41",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.61,
        "w": 0.202,
        "x": 0.346,
        "y": 0.201
      },
      "kind": "list",
      "text": "Continued Momentum in Key Portfolios\n+14% reported revenue growth Ocuvite® + PreserVision®\nPreserVision® has ~95% market share in U.S.3\n+14% organic revenue growth1,2 in surgical implantables, driven by premium and standard IOLS",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d9eef73a-300b-4bf5-8a03-20bd88298d75",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.24,
        "w": 0.249,
        "x": 0.05,
        "y": 0.194
      },
      "kind": "list",
      "text": "Bausch + Lomb 3Q22 vs. 3Q21\n(1%) 3Q22 Reported Revenue\n5% 3Q22 Organic Revenue1,2\n5% 3Q22 Constant Currency1",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f95ea765-53ef-4ee6-919b-38dde25b343c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.58,
        "x": 0.16,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "1. This is a non-GAAP measure or ratio. See Slide 2 and Appendix for further information on non-GAAP measures and ratios.\n2. Organic revenue growth/change, a non-GAAP ratio, is defined as a change on a period-over-period basis in revenues on a constant currency basis (if applicable) excluding the impact of acquisitions, divestitures and discontinuations.\n3. IRI Panel Omnichannel\n4. IQVIA NSP.\n5. Clarivate. See Slide 1 for further information on forward-looking statements.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a08a5eee-c423-43c9-bd2f-068fff134d1c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.906,
        "x": 0.049,
        "y": 0.04
      },
      "kind": "title",
      "text": "3Q22 Highlights: Organic Revenue Growth1,2 in All Three Segments Despite Inflation and FX Headwinds",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "02e8cde9-344a-4cc1-8d84-b64a4bcae2ef",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 9,
      "from": 6,
      "beatId": "a56f4739-afad-4b91-b821-f4c821080ec5",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Need",
      "beatSlug": "monroes-sequence-need",
      "evidence": "The deck highlights the company's standalone opportunity and 3Q22 financial highlights.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 9,
      "from": 8,
      "name": "Pattern Hunter",
      "slug": "02-pattern-hunter",
      "bestFor": "Time-pressed audiences, building consensus, when data is strong",
      "matchId": "2db31f9e-b83f-42ae-bc1e-3fdb56dcace3",
      "evidence": "The deck highlights organic revenue growth in all three segments.",
      "position": 0,
      "objective": "To identify patterns in Bausch + Lomb's revenue growth",
      "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
      "confidence": 0.6,
      "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}